未登录

K

Karin Hjort

Uppsala University

H指数:20

被引数:2,640

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Isolation and characterization of novel lytic bacteriophages against (fluoro)quinolone-resistant Campylobacter strains

分离和表征针对氟喹诺酮耐药性Campylobacter菌株的新型裂解性噬菌体

Frontiers in Microbiology

IF4.5

2026-01-020

OAAI

Deletions of recombination genes impair tandem amplification and reshape heteroresistance mechanisms in Escherichia coli

重组基因的缺失损害串联扩增并重塑大肠杆菌的异质性耐药机制

IF4.7

2026-01-010

PRE

Linoleic acid addition prevents Staphylococcus aureus biofilm formation on PMMA bone cement

亚油酸添加可预防金黄色葡萄球菌在PMMA骨水泥上形成生物膜

IF4.9

2025-08-070

OAAI

Influence of printing configuration on the resulting topology and antibacterial effectiveness of PVDF-graphene composites

打印配置对PVDF-石墨烯复合材料最终拓扑结构和抗菌效果的影响

Polymer Testing

IF6

2025-06-130

OA

Heteroresistance and clinical outcomes: much still to be understood–Authors’ reply

异质性耐药与临床结局：尚有许多待了解之处——作者回复

IF0

2025-05-010

OAAI

Influence of surface characteristics of polypropylene on E. coli and S. aureus biofilms: From conventional to additive manufacturing of bioprocess equipment

APPLIED MATERIALS TODAY

IF6.9

2024-08-013

OAAI

Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance

NATURE COMMUNICATIONS

IF15.7

2024-05-103

OAAI

Heteroresistance to piperacillin/tazobactam in Klebsiella pneumoniae is mediated by increased copy number of multiple β-lactamase genes

肺炎克雷伯菌对哌拉西林/他唑巴坦的异质性耐药由多种β-内酰胺酶基因拷贝数增加介导。

JAC-ANTIMICROBIAL RESISTANCE

IF3.3

2024-04-101

OAAI

Antibiotic Minimal Selective Concentrations and Fitness Costs during Biofilm and Planktonic Growth

IF4.7

2022-06-2810

OAAI

The highly dynamic nature of bacterial heteroresistance impairs its clinical detection

COMMUNICATIONS BIOLOGY

IF5.1

2021-05-0534

OAAI

A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy

SCIENTIFIC REPORTS

IF3.9

2021-02-1814

OAAI

Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics

IF3.1

2020-10-2811

OAAI

Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2020-10-1212

OAAI

Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2020-06-016

PREAI

Inhibition of translation termination by small molecules targeting ribosomal release factors (vol 9, 15424, 2019)

SCIENTIFIC REPORTS

IF3.9

2020-03-130

OAAI

Inhibition of translation termination by small molecules targeting ribosomal release factors

SCIENTIFIC REPORTS

IF3.9

2019-10-288

OAAI

Mechanisms and clinical relevance of bacterial heteroresistance

NATURE REVIEWS MICROBIOLOGY

IF103.3

2019-06-24291

PREAI

Evolution of high-level resistance during low-level antibiotic exposure

NATURE COMMUNICATIONS

IF15.7

2018-04-23309

OAAI

Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2016-09-2078

OAAI

Time lapse investigation of antibiotic susceptibility using a microfluidic linear gradient 3D culture device

IF5.4

2014-01-0166

PREAI